MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
stockNASDAQ
maravai lifesciences catalyzes the growth of successful, entrepreneurial life science companies by providing expertise, capital, processes and systems so that they can continue to serve scientists who are striving to improve human health. current maravai lifesciences portfolio companies provide enabling tools and services in the life sciences research and bioproduction industries that accelerate breakthrough discoveries in areas such as genomics, proteomics, and biotherapeutic development. maravai lifesciences was formed in march 2014 through a partnership with gtcr, a leading private equity firm. our mission is to build a transformative life sciences reagents company by acquiring outstanding businesses and accelerating their growth. since our founding, we have acquired four companies, each a leader in its market segment. vector laboratories has led the market for labeling and detection products used by researchers in immunohistochemistry, immunofluorescence and related techniques. tri
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 7.63 | 2026-09-28 | +3.47% | 5.155 |
| 1M | 7.32 | 2026-09-04 | +7.86% | 1.911 |
| 3M | 5.90 | 2026-07-06 | +33.81% | 0.846 |
| 6M | 2.95 | 2026-04-06 | +167.63% | 0.974 |
| 1Y | 3.09 | 2025-10-03 | +155.50% | 1.275 |
| 2Y | 7.89 | 2024-10-04 | +0.06% | — |
| 5Y | 42.77 | 2021-10-04 | -81.54% | 1.099 |
Maravai LifeSciences Holdings, Inc. Class A Common Stock (NASDAQ:MRVI) stock price today is $7.90, and today's volume is 1,913,829. MRVI is up 5.267% today. The 30 day average volume is 3.36M. MRVI market cap is $1.18B with 148.99M shares outstanding.